Cluep, with Confideo Media for Coherus Biosciences
LOQTORZI, from Coherus Biosciences, is a treatment for nasopharyngeal cancer (NPC), a rare kind of cancer. The brand sought to utilize progressive media platforms to efficiently and effectively elevate awareness of the disease and the approved treatment across stakeholders, including targeted prescribers, patients, and caregivers. Confideo Media, which manages non-personal media for Coherus Biosciences, partnered with Cluep, a pioneer of artificial intelligence and creators of advanced neural networks, to achieve this goal.
Cluep’s innovative technology identifies, qualifies, and connects critical messaging with targeted stakeholders using advanced AI models to analyze text, image, video, and audio data across social platforms. In real-time, the technology qualifies relevant activity and derives intent, enabling the identification of engaged healthcare professionals, patients, and caregivers. Subsequently, the technology then enables the delivery of contextually relevant targeted media in real-time as individuals continue their online journey, creating highly effective real-time segments for display and video.
Cluep’s progressive technology unlocked meaningful and measurable value for LOQTORZI by identifying, qualifying, and connecting qualified stakeholders to educational content and critical medical media. The initiative, deployed across HCP and DTP segments, delivered impressive performance, outperforming industry benchmarks, and far exceeding client expectations. As an example, the HCP campaign achieved a 4% action rate (2x the client benchmark) and greater than 1.00% CTR (10x industry benchmark). In addition, the DTP campaign drove an impressive 51,335 clicks, achieving a 3% action rate and a .95% CTR. As a result, LOQTORZI reached an exponentially larger group of qualified prescribers, patients, and caregivers.
According to Mike Marett, Founder and CEO of Confideo, “Embracing the future, our clients are at the industry’s forefront, revolutionizing the pharmaceutical marketing landscape with Cluep’s cutting-edge technology. This new wave of innovation is transforming how pharma brands deliver content-personalized, contextually relevant, and perfectly timed, all through the most effective channels.”
FINALISTS:
Advancing Care: Harnessing AI to Empower the Hard-to-Reach Patient Audience (argenx, Avalere Health, and DxCheck)
Genentech’s Health-Modeled Audience Reach Initiative (Genentech, Inc.)
Harness Data for Impact (Accord Biopharma, Inc. and Asentech, LLC)
LOQTORZI DTP + HCP (Cluep, with Confideo Media for Coherus Biosciences)
Successful Script Lift Among Hard-to-Reach Patients in the OptimizeRx Dynamic Audience Activation Platform (DAAP) (OptimizeRx)
